Integrated Wealth Concepts LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 12.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,745 shares of the healthcare conglomerate's stock after acquiring an additional 2,917 shares during the quarter. Integrated Wealth Concepts LLC's holdings in UnitedHealth Group were worth $13,529,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Howard Capital Management Group LLC bought a new position in UnitedHealth Group during the third quarter worth $341,000. Principal Financial Group Inc. increased its position in UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after buying an additional 180,479 shares in the last quarter. McIlrath & Eck LLC grew its stake in UnitedHealth Group by 8.2% in the third quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate's stock valued at $371,000 after acquiring an additional 48 shares during the period. SOA Wealth Advisors LLC. raised its position in shares of UnitedHealth Group by 3.7% during the third quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate's stock worth $746,000 after purchasing an additional 46 shares during the period. Finally, Tudor Financial Inc. acquired a new position in UnitedHealth Group during the third quarter worth $900,000. Institutional investors and hedge funds own 87.86% of the company's stock.
Analyst Ratings Changes
UNH has been the topic of a number of analyst reports. JPMorgan Chase & Co. lowered their target price on shares of UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating on the stock in a report on Thursday. KeyCorp dropped their target price on UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Truist Financial dropped their price objective on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research note on Monday, April 21st. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a report on Tuesday. Finally, Barclays decreased their price objective on shares of UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Three equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Buy" and a consensus target price of $603.05.
Check Out Our Latest Stock Analysis on UNH
UnitedHealth Group Stock Performance
Shares of NYSE UNH traded down $6.05 during mid-day trading on Friday, hitting $418.20. The company had a trading volume of 9,255,934 shares, compared to its average volume of 4,482,211. UnitedHealth Group Incorporated has a 1 year low of $412.02 and a 1 year high of $630.73. The stock's 50-day moving average price is $503.28 and its 200-day moving average price is $534.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $380.66 billion, a price-to-earnings ratio of 26.98, a P/E/G ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the firm posted $6.91 EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 2.01%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.